Walder Wyss advised Alentis Therapeutics on the deal. Honigman advised Catalio Capital Management. Alentis Therapeutics raised $181.4 million in Series D financing, supported by a syndicate...
You must be a Standard 1 Year member to access this content.
Walder Wyss advised the ITS shareholders in this transaction. GEODIS, one of the world’s leading transport and logistics companies, has acquired Swiss freight forwarder ITS –...
You must be a Standard 1 Year member to access this content.
Walder Wyss advises Alentis Therapeutics on the financing. Alentis Therapeutics has announced $105 million in Series C financing. The funding round was led by Jeito Capital...
You must be a Standard 1 Year member to access this content.
Walder Wyss advised Distalmotion in connection with the transaction. Bär & Karrer advised Revival Healthcare Capital alongside Wilson Sonsini in this transaction. Distalmotion SA, a young,...
You must be a Standard 1 Year member to access this content.
Bär & Karrer acted as legal advisor to Cawood Scientific. Walder Wyss advised IES’ shareholders in this transaction. Cawood Scientific, UK’s leading independent scientific group, announced...
You must be a Standard 1 Year member to access this content.
